ON-DEMAND WEBINARS

In this presentation, a distinguished panel of experts illuminates the crucial role of patient-reported outcomes (PROs) in shaping regulatory decisions and drug development strategies.

Consider new perspectives on 2023-issued guidance by the EMA and FDA, and how the amalgamation of these directives, combined with scientific insights, can empower sponsors and biotech firms.

Join industry leaders from Anju and 9 Labs for a presentation on the pivotal role of Strategic Communication Plans (SCP) in medical affairs.

Discover how streamlined workflows and enhanced collaboration between data managers and medical reviewers can boost clinical trial efficiency, improve data quality, and ensure patient safety.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

John Oncea Editor